Skip to main content
Clinical Trials/NCT03695484
NCT03695484
Unknown
N/A

Prospective, Multicenter, Non-randomized Observational Registry Conducted at High Volume Experienced Treatment Centers Utilizing the Most Current AF Ablation Techniques.

Erasmus Medical Center3 sites in 3 countries212 target enrollmentOctober 31, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Erasmus Medical Center
Enrollment
212
Locations
3
Primary Endpoint
Fluoroscopy time
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this observational registry is to prospectively collect procedure efficiency, safety and acute and long term outcome data from catheter ablation procedures as treatment of paroxysmal atrial fibrillation, using the following treatment modalities:

  • Cryoballoon ablation
  • Manual guided RF ablation using Contact Force catheters
  • Remote Magnetic Navigation guided RF ablation with e-Contact and high power settings
  • Remote Magnetic Navigation guided RF ablation with e-Contact and low power settings
Registry
clinicaltrials.gov
Start Date
October 31, 2018
End Date
June 30, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Anne-Marie Noten

Principal investigator

Erasmus Medical Center

Eligibility Criteria

Inclusion Criteria

  • Documented Paroxysmal Atrial Fibrillation
  • Eligibility for Pulmonary Vein Isolation by catheter ablation based on the respective ACC/AHA/ESC Guideline valid at the date of procedure
  • Signed the informed consent to participate in the registry

Exclusion Criteria

  • Younger than 18 years of age
  • Prior AF ablation procedure (including MAZE procedure)
  • Prior ablation of Non-AF Arrhythmia within 3 months of enrollment
  • Presence of cardiac thrombus
  • Other AF ablations performed during procedure (e.g. lines, rotor, CFAE's etc)
  • Active endocarditis or systemic infection
  • Life expectancy \< 1 year
  • Pregnancy

Outcomes

Primary Outcomes

Fluoroscopy time

Time Frame: During ablation procedure

Fluoroscopy time (minutes)

Left atrial dwell time

Time Frame: During ablation procedure

Left atrial dwell time (time from LA entry until removal of catheters) (minutes)

Transseptal time

Time Frame: During ablation procedure

Transseptal time (time from insertion of catheters until transseptal puncture) (minutes)

Ablation time per pulmonary vein

Time Frame: During ablation procedure

Ablation time per pulmonary vein (minutes)

PVI ablation time

Time Frame: During ablation procedure

PVI ablation time (total PVI ablation time, i.e. first until last application) (minutes)

Procedure time

Time Frame: During ablation procedure

Procedure time (minutes)

Secondary Outcomes

  • First Pass Isolation(During ablation procedure)
  • Acute success(During ablation procedure)
  • Procedure-related adverse-events(From the date of procedure until 7 days)
  • TouchUp rates(During ablation procedure)
  • Long-term success(From the date of procedure until 1 year)
  • Long-term adverse events(From the date of procedure until 1 year)

Study Sites (3)

Loading locations...

Similar Trials